Several federal courts have issued preliminary injunctions blocking the Biden Administration from enforcing its federal contractor COVID-19 vaccine mandate.  As discussed in our previous posts, President Biden issued Executive Order 14042 mandating that employees of federal contractors and subcontractors be vaccinated against COVID-19 and take various other workplace safety measures.  Executive Order 14042 relies on the president’s authority under the U.S. Constitution and the Federal Property and Administrative Services Act (“FPASA”) to effectuate this policy.  Prior to issuance of the injunctions, contractors were required to have covered employees fully vaccinated by January 18, 2022.

Numerous states have sued in federal court to block the mandate.  The U.S. District Court for the Eastern District of Kentucky was the first to act, entering a preliminary injunction on November 30, 2021 that enjoins enforcement of the mandate on all covered contracts in Kentucky, Ohio, and Tennessee.  This was followed by a national preliminary injunction issued by the U.S. District Court for the Southern District of Georgia on December 7, 2021, and further rulings in favor of the challengers issued by the U.S. District Courts for the Western District of Louisiana, the Eastern District of Missouri, the Middle District of Florida, and the District of Arizona on December 16, 20, and 22, 2021, and January 27, 2022, respectively.  The Louisiana preliminary injunction is limited by entity rather than geography—it enjoins enforcement of the mandate in any contract, grant, or other like agreement between the federal government and the states of Louisiana, Indiana, and Mississippi, or their agencies.   The Missouri, Florida, and Arizona preliminary injunctions, on the other hand, like that in Kentucky, are limited by geography—the first enjoins enforcement of the mandate on all covered contracts in Missouri, Nebraska, Alaska, Arkansas, Iowa, Montana, New Hampshire, North Dakota, South Dakota, and Wyoming, the second enjoins enforcement in Florida, and the third in Arizona.  The Biden Administration has appealed the first four decisions and we expect it to appeal the Arizona one as well.  The Administration has also sought stays of the underlying cases and other challenges pending those appeals.  This post provides a summary of the injunctions that have issued thus far as well as the status of each case challenging the contractor vaccine mandate.

The decision in Kentucky rests primarily on a finding that President Biden “exceeded his delegated authority under” FPASA in promulgating Executive Order 14042.  Specifically, the judge in Kentucky found that the contractor vaccine mandate lacked sufficient nexus to the purpose of FPASA, which, in the judge’s opinion, is to create an economical and efficient system for procurement and supply.  The judge suggested that an alternative approach could lead to “enact[ing] virtually any measure at the president’s whim under the guise of economy and efficiency.”  In support of this conclusion, the judge cited a recent Supreme Court ruling that the administration did not have authority to impose a nationwide eviction moratorium under a public health statute, but did not delve into the differences between affirmatively regulating private parties and applying conditions to the terms of government contracts. The judge further found that, by exceeding his authority under FPASA, President Biden likely violated the Competition in Contracting Act by potentially excluding contractors who represent the best value to the government, the nondelegation doctrine by using a procurement statute to promulgate a vaccine mandate, and the Tenth Amendment by intruding into an area of law traditionally reserved for the states.

Based on these findings, the judge concluded that the states have a strong likelihood of success on the merits of their suit.  The judge rejected—at least for now—the states’ arguments that the mandate also violates the Spending Clause and various administrative procedure requirements.  The ruling is limited to the three states that are party to that suit.  Thus, it enjoins the federal government only from enforcing the vaccine mandate “for federal contractors and subcontractors in all covered contracts in Kentucky, Ohio, and Tennessee.”

The Georgia, Missouri, Arizona, and Florida decisions rest on findings similar to those articulated in the Kentucky opinion (i.e. primarily, that President Biden likely exceeded his authority under FPASA).  The Florida decision further relies on a finding that the vaccine mandate violates the Tenth Amendment by intruding into an area of law traditionally reserved to the states.  Although the Missouri and Florida injunctions are limited to all covered contracts in the states participating in those lawsuits, the Georgia injunction applies nationwide, enjoining the Biden Administration “from enforcing the vaccine mandate for federal contractors and subcontractors in all covered contracts in any state or territory of the United States of America.”  The Arizona decision is discussed more in depth in our updated alert posted in February 2022.

The decision in Louisiana, in contrast, rests on the Tenth Amendment and is limited to contracts involving the states participating in that lawsuit.  The court found that a “reasonably sufficient nexus can exist between EO 14042 and the government’s policy under FPASA to procure and manage properties in an economical and efficient manner” but was “convinced that EO 14042 conflicts with the Tenth Amendment.”  The judge determined that the Executive Order “was clearly and unequivocally motivated by public health policy first and foremost.”  Because it reasoned that the Constitution principally entrusts the safety and health of the people to the states, the Louisiana court concluded that Executive Order 14042 violated the Tenth Amendment’s reservation to the states of rights not delegated to the federal government.  The judge also determined that the plaintiffs were likely to establish that the administration violated the Administrative Procedure Act in promulgating the vaccine mandate.  The judge doubted, however, whether the states had standing to defend their citizens from Executive Order 14042, and concluded “it appears that private contractor[s] seeking to evade EO 14042 and its implementation must file suit” themselves.  He thus enjoined enforcement of the mandate only “in any contract, grant, or other like agreement, . . . whether for services or product and whether existing or new, between” Louisiana, Indiana, and Mississippi, or their agencies, and the federal government.

Determining how the various injunctions will be implemented is not clear.  For example, do the injunctions apply to the workplace safety aspects of the mandate as much as the vaccination portions?  The Georgia court has made clear that its national preliminary injunction does not.  Based on the language of the other courts’ orders and the breadth of those judges’ reasoning, however, the other injunctions may.  The other courts will hopefully further explain their rulings in the near future.

Nevertheless, these orders are not set in stone.  As noted, the Biden Administration has appealed all of the injunctions issued to date.  It has also sought stays of enforcement of the injunctions pending appeal from both the district courts and the responsible Circuit Courts, though those that have been ruled on have been denied. The administration has also sought to stay many of the other cases challenging the contractor mandate pending the appeals.

These other similar state challenges to the federal contractor vaccine mandate remain in various stages. A summary of the status of each case and each appeal, all of which involve allegations and claims that are similar to those at issue in Kentucky, Georgia, Louisiana, Missouri, Arizona, and Florida, is set forth below.

Arizona Lawsuit

  • On September 15, 2021, Arizona filed a lawsuit in the U.S. District Court for the District of Arizona challenging the federal contractor vaccine mandate.
  • On January 27, 2022, the court issued a preliminary injunction effective in Arizona.
    • *We anticipate that the Biden administration will appeal the injunction to the Ninth Circuit.

Florida Lawsuit

  • On October 28, 2021, Florida filed a lawsuit in the U.S. District Court for the Middle District of Florida challenging the federal contractor vaccine mandate.
  • On December 30, 2021, the court entered a preliminary injunction effective in Florida based on its Dec. 23, 2021 ruling.
    • The Biden Administration has appealed the injunction to the Eleventh Circuit.
  • Since the Biden administration filed for appeal,
    • The Eleventh Circuit has:
      • Ordered briefing to be completed by approximately April 13, 2022.
      • Received an unopposed motion to vacate the briefing schedule and hold the appeal in abeyance pending resolution of the appeal in the Georgia suit, which is also being heard by the Eleventh Circuit.
    • The district court has:
      • Stayed further proceedings pending resolution of the appeal, except to the extent it intends to address the balance of the motion for a preliminary injunction that it retained under advisement.

Georgia Lawsuit

  • On October 29, 2021, seven states (Georgia, Alabama, Idaho, Kansas, South Carolina, Utah, and West Virginia) filed a lawsuit in the U.S. District Court for the Southern District of Georgia challenging the federal contractor vaccine mandate.
  • On December 7, 2021, the court issued a preliminary injunction effective on all covered contracts nation-wide.
    • The Biden Administration has appealed the injunction to the Eleventh Circuit.
  • Since the Biden administration filed for appeal,
    • The Eleventh Circuit has:
      • Denied the Biden Administration’s motion to stay the injunction pending appeal.
      • Expedited the appeal. Briefing is to be completed by February 22, 2022. Oral argument is scheduled for April 8, 2022.
    • The district court has:
      • Stayed further proceedings pending final resolution of the appeal.
      • Denied the Biden Administration’s request to “clarify” the scope of the preliminary injunction, but in doing so made clear that it applies only to the vaccine portion of the mandate (i.e. it does not apply to the workplace safety aspects of the mandate, such as the requirements for masking and physical distancing).

Missouri Lawsuit

  • On October 29, 2021, ten states (Missouri, Nebraska, Alaska, Arkansas, Iowa, Montana, New Hampshire, North Dakota, South Dakota, and Wyoming) filed a lawsuit in the U.S. District Court for the Eastern District of Missouri challenging the federal contractor vaccine mandate.
  • On December 20, 2021, the court issued a preliminary injunction effective in Missouri, Nebraska, Alaska, Arkansas, Iowa, Montana, New Hampshire, North Dakota, South Dakota, and Wyoming.
    • The Biden Administration has appealed the injunction to the Eighth Circuit.
  • Since the Biden administration filed for appeal,
    • The Eighth Circuit has:
      • Ordered briefing to be completed by approximately May 2, 2022.
    • The district court has:
      • Stayed further proceedings pending resolution of the appeal.

Texas Lawsuit

  • On October 29, 2021, Texas filed a lawsuit in the U.S. District Court for the Southern District of Texas challenging the federal contractor vaccine mandate.
  • On December 10, 2021, the court stayed the case.

Kentucky Lawsuit

  • On November 4, 2021, three states (Kentucky, Ohio, and Tennessee) filed a lawsuit in the U.S. District Court for the Eastern District of Kentucky challenging the federal contractor vaccine mandate.
  • On November 30, 2021, the court issued a preliminary injunction effective on all covered contracts in Kentucky, Ohio, and Tennessee.
    • The Biden Administration has appealed the injunction to the Sixth Circuit.
  • Since the Biden administration filed for appeal,
    • The Sixth Circuit has:
      • Denied the Biden Administration’s motion to stay the injunction pending appeal.
      • Ordered briefing to be completed by March 23, 2022.
    • The district court has:
      • Denied the administration’s motion to stay the injunction pending appeal.
      • Stayed further proceedings pending final resolution of the appeal.

Louisiana Lawsuit

  • On November 4, 2021, three states (Louisiana, Indiana and Mississippi) filed a lawsuit in the U.S. District Court for the Western District of Louisiana challenging the federal contractor vaccine mandate.
  • On December 16, 2021, the district court:
    • Issued a preliminary injunction effective on all contracts between the federal government and Louisiana, Indiana, and Mississippi, or their agencies
      • The Biden Administration has appealed the injunction to the Fifth Circuit.
    • Stayed further proceedings pending further appellate action.
  • Since the Biden administration filed for appeal,
    • The Fifth Circuit has:
      • Ordered briefing on the appeal of the injunction decision to be completed by May 2, 2022.

Oklahoma Lawsuit

    • On November 4, 2021, Oklahoma filed a lawsuit in the U.S. District Court for the Western District of Oklahoma challenging the federal contractor vaccine mandate.
    • On December 13, 2021, briefing on Oklahoma’s request for a preliminary injunction was completed.
    • In January 2022, the parties filed supplemental briefing on the impact of recent SCOTUS decisions regarding the OSHA and CMS vaccination mandates.

In light of the many upcoming decisions to be issued and the significant possibility of conflicting orders, we expect to see significant developments in this area in the coming weeks.  Although it is possible that the various cases could be consolidated before a single district court, it currently appears that these matters will continue to proceed in a traditional fashion, i.e., decisions rendered by each district court which then are appealed to the responsible Circuit Court.  (This contrasts with the challenges to the OSHA emergency temporary standard on COVID-19, which were filed directly to the appellate courts pursuant to a special provision in OSHA’s animating statute and which was heard by a single appellate court chosen by lottery before being appealed to the Supreme Court.)  Ultimately, to resolve conflicts between Circuit Court decisions, or on review from a consolidated appeal, the federal contractor vaccine mandate must be addressed by the Supreme Court.

We will provide updates as events unfold and the deadline for vaccinations approaches.  Meanwhile, it is important to remember that although the issued preliminary injunctions enjoin the federal government from enforcing the contractor vaccine mandate, they do not preclude employers from unilaterally imposing their own vaccine requirements as they await resolution of this issue.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Frederic Levy Frederic Levy

Fred Levy is senior counsel in the firm’s Government Contracts and White Collar Defense and Investigations Practice Groups. He is a leading suspension and debarment lawyer, focusing his practice on the resolution of complex compliance and ethics issues. He has successfully represented numerous…

Fred Levy is senior counsel in the firm’s Government Contracts and White Collar Defense and Investigations Practice Groups. He is a leading suspension and debarment lawyer, focusing his practice on the resolution of complex compliance and ethics issues. He has successfully represented numerous high-profile corporations and individuals under investigation by the government in civil and criminal matters, including False Claims Act cases, and in suspension and debarment proceedings to ensure their continued eligibility to participate in federal programs. He has also conducted numerous internal investigations on behalf of corporate clients and advises corporations on voluntary or mandatory disclosures to federal agencies. Fred regularly counsels clients on government contract performance issues, claims and terminations, and litigates matters before the boards of contract appeals and in the Federal Circuit.

Related to his work involving program fraud, Fred counsels clients in the area of contractor “responsibility.” He is involved in the development and implementation of contractor ethics and compliance programs that meet the standards of the Federal Acquisition Regulation, Federal Sentencing Guidelines, and Sarbanes-Oxley, and he regularly conducts ethics and compliance training.

Fred is a principal editor of Guide to the Mandatory Disclosure Rule, and of The Practitioner’s Guide to Suspension and Debarment, 4th Edition. He is a vice-chair of the Debarment and Suspension Committee of the ABA Public Contract Law Section, and a former co-chair of that committee and of the Procurement Fraud Committee. He is a graduate of Columbia College and Columbia Law School.

Photo of Jennifer Plitsch Jennifer Plitsch

Jennifer Plitsch leads the firm’s Government Contracts Practice Group, where she works with clients on a broad range of issues arising from both defense and civilian contracts including contract proposal, performance, and compliance questions as well as litigation, transactional, and legislative issues.

She…

Jennifer Plitsch leads the firm’s Government Contracts Practice Group, where she works with clients on a broad range of issues arising from both defense and civilian contracts including contract proposal, performance, and compliance questions as well as litigation, transactional, and legislative issues.

She has particular expertise in advising clients on intellectual property and data rights issues under the Federal Acquisition Regulations (FAR) and obligations imposed by the Bayh-Dole Act, including march-in and substantial domestic manufacturing. Jen also has significant experience in negotiation and compliance under non-traditional government agreements including Other Transaction Authority agreements (OTAs), Cooperative Research and Development Agreements (CRADAs), Cooperative Agreements, Grants, and Small Business Innovation Research agreements.

For over 20 years, Jen’s practice has focused on advising clients in the pharmaceutical, biologics and medical device industry on all aspects of both commercial and non-commercial agreements with various government agencies including:

  • the Department of Veterans Affairs (VA);
  • the Department of Health and Human Services (HHS), including the Biomedical Advanced Research and Development Authority (BARDA), the National Institutes of Health (NIH), and the Centers for Disease Control (CDC);
  • the Department of Defense (DoD), including the Defense Threat Reduction Agency (DTRA), the Defense Advanced Research Projects Agency (DARPA), and the Joint Program Executive Office for Chemical Biological Defense (JPEO-CBRN); and
  • the U.S. Agency for International Development (USAID).

She regularly advises on the development, production, and supply to the government of vaccines and other medical countermeasures addressing threats such as COVID-19, Ebola, Zika, MERS-CoV, Smallpox, seasonal and pandemic influenza, tropical diseases, botulinum toxin, nerve agents, and radiation events. In addition, for commercial drugs, biologics, and medical devices, Jen advises on Federal Supply Schedule contracts, including the complex pricing requirements imposed on products under the Veterans Health Care Act, as well as on the obligations imposed by participation in the 340B Drug Pricing program.

Jen also has significant experience in domestic sourcing compliance under the Buy American Act (BAA) and the Trade Agreements Act (TAA), including regulatory analysis and comments, certifications, investigations, and disclosures (including under the Acetris decision and Biden Administration Executive Orders). She also advises on prevailing wage requirements, including those imposed through the Davis-Bacon Act and the Service Contract Labor Standards.

Photo of A.J. Carvalho A.J. Carvalho

A.J. Carvalho advises medical device, pharmaceutical, biotechnology, and laboratory companies on FDA regulatory and compliance issues. He has assisted clients on myriad matters, including in complying with FDA regulations, responding to FDA enforcement actions and Congressional inquiries, conducting due diligence of FDA-regulated companies…

A.J. Carvalho advises medical device, pharmaceutical, biotechnology, and laboratory companies on FDA regulatory and compliance issues. He has assisted clients on myriad matters, including in complying with FDA regulations, responding to FDA enforcement actions and Congressional inquiries, conducting due diligence of FDA-regulated companies, and resolving issues that arise during product development.

Prior to joining the Food, Drug, and Device practice group, A.J. was a member of the Patent Litigation and White Collar Defense and Investigation Practice Groups. As a member of the Patent Litigation Practice Group, A.J. focused on representing pioneer pharmaceutical and biotechnology companies in Hatch-Waxman patent litigation. As a member of the White Collar Defense and Investigations Practice Group, A.J. focused on helping medical device, pharmaceutical, and biotechnology companies navigate civil and criminal investigations by the Department of Justice and FDA.

Prior to joining Covington, A.J. was a clinical research coordinator at Walter Reed National Military Medical Center focused on exploratory clinical research related to blast injuries (including amputations), advanced prosthetics (including myoelectric prosthetic control), and other concomitant conditions. His research and work has been published in numerous scientific peer-reviewed journals.